Abstract
THIS REPORT WILL:
- Provide a detailed analysis of the excipients market today and a forecast
of what the market will look like in 5 years
- Offer information on inert ingredients, the types of technologies used to
make them, their uses, and regulatory influences
- Highlight excipients by chemical compounds, functional uses, delivery
systems and finished products
- Report on a global supply-chain crisis, which prominently involves
excipients; hundreds of people have died in several countries because of
adulterated pharmaceutical materials from China, and the crisis will take
years to fix
- Profile leading industry participants.
INTRODUCTION
REASONS FOR THE STUDY
Powerful forces affect the global excipients industry in 2009, including a
crisis in the global supply chain, the demands of Quality by Design (QbD),
worries about drug safety, new legislation in the offing, a need for new
excipients, exciting ideas for unlocking the industry' s creativity, and new
levels of cooperation between major players (e.g., Dow and Colorcon). These
forces are reshaping the business rapidly. In addition, as if these factors
were not enough, companies are also contending with a nasty recession.
Up-to-date information is essential for competitors.
GOALS AND OBJECTIVES
The primary goals of this technical/market report are to provide a detailed
analysis of the excipients market today and a forecast of what the market will
look like in 5 years. The specific objectives (1) identify excipients being
used; (2) quantify global market volume; (3) track important developments; (4)
analyze the structure of the industry and its driving forces; (5) examine the
most active companies and describe how they respond to market demands; and (6)
provide data with which the reader can further evaluate the industry.
INTENDED AUDIENCE
As a market and technology summary, this report consolidates a wide range of
industrial and technical information that should aid excipient suppliers,
chemical companies, drug manufacturers, healthcare regulators, and
congressional staffers keep current with today' s marketplace. The report
should be of value to companies interested in entering or expanding their
involvement in the field. The report should provide senior marketing personnel
and executive planners with insight about what materials can best satisfy
customer demands. Market projections may be of interest to venture capitalists
interested in exploring commercialization opportunities, as well as companies
and personnel involved in designing and constructing chemical and excipient
manufacturing plants and/or those who service such plants. The report offers
useful background to consultants in the field. The report can serve as an
introductory resource for newcomers to the business, including new employees.
In addition, the report can offer background to governmental officials
examining reform.
SCOPE OF REPORT
Excipients in Pharmaceuticals offers coverage of the most important issues
surrounding excipients: technological, regulatory, economic, political, and so
on.
Excluded from the study are ingredients for cosmetics, personal care, food,
quasi-medical, unorthodox, alternative, home remedies, underground and/or
illegal drugs, and veterinary drugs.
This report organizes information from diverse sources into sections entitled
Summary, Overview, Technology, Industry Structure, and Company Profiles. The
Summary encapsulates several key conclusions and includes a table of market
findings. The Overview provides deep background on the burning issues of the
day, including the global supply chain crisis, QbD, and legislative prospects.
The Technology section examines excipients by chemical compounds, functional
uses, and delivery systems, and as finished products. The Industry Structure
section discusses the market environment, strategies, influences, market
shares, international aspects, and other related factors. The Company Profiles
segment provides summaries of more than 120 companies that supply excipients
or are relevant to the industry.
METHODS AND SOURCES
The methodology used to create Excipients in Pharmaceuticals included
extensive telephone interviews with key executives of leading U.S. and
European companies and consultancies. This commentary was combined with
information gleaned from websites, annual reports, the trade press, textbooks,
patents, press releases, and government documents.
The information has been used to project and forecast market size, and
calculate compound annual growth rates (CAGRs) of the overall market and many
market segments. All market sizes refer to worldwide values and volumes, which
are rounded to the nearest million in dollars and lbs. Market size is
estimated at the manufacturer level; that is, the level of consumption in
actual drug formulations. Where precise information was not available, a
consensus was made using a formulation of reasonable assumptions and estimates
based on historical data. In this report, the market size for 2008 serves as a
base for making estimates for 2009 and projections to 2014.
| 
View Cart
